Acuity Inc. shares fall 1.33% intraday as Amgen reports strong Q2 2025 financial results.

miércoles, 6 de agosto de 2025, 3:57 pm ET1 min de lectura
AYI--
Acuity Inc. declined 1.33% in intraday trading. Amgen reported strong second-quarter 2025 financial results, with total revenues increasing 9% to $9.2 billion compared to the same period in 2024. Product sales grew 9%, driven by 13% volume growth, partially offset by a 3% lower net selling price.

Acuity Inc. shares fall 1.33% intraday as Amgen reports strong Q2 2025 financial results.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios